title: Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents.
abstract: BACKGROUND
  Multiple sclerosis (MS) treatment options are primarily limited to immunomodulatory therapies in MS non-progressive forms. Nutrition intervention studies suggest that diet may be considered as a complementary treatment to control disease progression. Therefore, dietary intervention may help to improve wellness and ameliorate symptoms of MS patients.
  
  
  OBJECTIVE
  To assess the effect of a low-fat diet with antioxidant supplementation on biochemical markers of institutionalized patients with progressive forms of multiple sclerosis.
  
  
  METHODS
  A randomized prospective placebo-controlled study involving 9 participants, 5 of them assigned to the intervention group (low-fat diet and antioxidant supplementation) and the other 4 to the placebo group (low-fat diet). The effect of the dietary intervention, involving diet modification and antioxidant supplementation, was examined for 42 days by measuring anthropometric, biochemical parameters and oxidative stress markers in blood at baseline (day 0), intermediate (day 15) and end (day 42) stages of the treatment.
  
  
  RESULTS
  The intervention group obtained C reactive protein levels significantly lower than those observed in the corresponding placebo group at the end of the study. Oxidative stress and inflammatory markers isoprostane 8-iso-PGF2α and interleukine IL-6 values also diminished after dietary intervention in the intervention group. Catalase activity increased significantly in the intervention group prior antioxidant supplementation. No significant differences were observed in other oxidative stress markers.
  
  
  CONCLUSIONS
  The results suggest that diet and dietary supplements are involved in cell metabolism modulation and MS-related inflammatory processes. Consequently, low fat diets and antioxidant supplements may be used as complementary therapies for treatment of multiple sclerosis.
authors: Institute of Food Science and Technology (ICTAL). University of León. Spain. State Reference Centre (CRE) of Disability and Dependency. San Andrés del Rabanedo. León. Spain.. elba.mauriz@unileon.es.
authors: Elba
authors: E
authors: Mauriz
authors: Institute of Biomedicine (IBIOMED), University of León. Spain..
authors: A
authors: A
authors: Laliena
authors: Institute of Biomedicine (IBIOMED), University of León. Spain..
authors: D
authors: D
authors: Vallejo
authors: Institute of Biomedicine (IBIOMED), University of León. Spain..
authors: M J
authors: MJ
authors: Tuñón
authors: Campofrio Food Group. Madrid. Spain..
authors: J M
authors: JM
authors: Rodríguez-López
authors: Campofrio Food Group. Madrid. Spain..
authors: R
authors: R
authors: Rodríguez-Pérez
authors: Institute of Food Science and Technology (ICTAL). University of León. Spain..
authors: M C
authors: MC
authors: García-Fernández
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D018752:Diet, Fat-Restricted; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000178:diet therapy*
chemical_list: D000975:Antioxidants; D015415:Biomarkers